FIELD: medicine, namely, therapy. SUBSTANCE: conjugate is compound having formula I [A-O-W-Z]a-T where A-O is residue of any anthracycline having formula A-O-H with at least one primary or secondary hydroxyl group; a is integer from 1 to 30; N is residue of formula (2) 
where B is C1-C6 alkylene group; , m is 0 or 1; z is spacer group; T is part of carrier. Proposed conjugates may be used as antitumor agents. EFFECT: improved quality of desired product, improved efficiency of the method. 26 cl, 2 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BINDING AGENT FOR BIOACTIVE PREPARATIONS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS | 1991 |
|
RU2116087C1 |
| ANTHRACYCLINE GLYCOSIDES AND THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS, METHOD OF THEIR SYNTHESIS, DIIODOINTERMEDIATE COMPOUND AND METHOD OF ITS SYNTHESIS | 1991 |
|
RU2100366C1 |
| DERIVATIVES OF 3'-AZIRIDINO-ANTHRACYCLINE, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149163C1 |
| N-PHENYLALKYL-SUBSTITUTED DERIVATIVES OF α-AMINOCARBOXAMIDE, METHOD OF THEIR SYNTHESIS, PHARMACOLOGICALLY ACTIVE COMPOSITION ON THEIR BASE AND A METHOD OF DISEASE DEVELOPMENT PROPHYLAXIS | 1992 |
|
RU2097371C1 |
| ACRYLOYL-SUBSTITUTED PYRROLE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF PREPARATION THEREOF | 1990 |
|
RU2094430C1 |
| ANTHRACYCLIN DERIVATIVES | 1995 |
|
RU2159619C2 |
| BIOLOGICALLY-ACTIVE POLYMER-BOUND ANTHRACYCLINES, INTERMEDIATES, PREPARATION METHODS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2145965C1 |
| ANTHRACYCLINE GLYCOSIDE AND METHOD OF ITS SYNTHESIS | 1992 |
|
RU2081878C1 |
| DERIVATIVES OF ANTHRACYCLINONE AND THEIR USE IN AMYLOIDOSIS | 1995 |
|
RU2167661C2 |
| ANTHRACYCLINE GLYCOSIDE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2118328C1 |
